A Chicago jury dismissed claims by Angela Valadez that the heartburn drug Zantac caused her colon cancer. The trial marks the first of many similar lawsuits. Drugmakers GSK and Boehringer Ingelheim successfully argued there was no scientific evidence connecting Zantac to cancer.